Sushilla Van Schoonhoven

Sushilla Van Schoonhoven

UNVERIFIED PROFILE

Are you Sushilla Van Schoonhoven?   Register this Author

Register author
Sushilla Van Schoonhoven

Sushilla Van Schoonhoven

Publications by authors named "Sushilla Van Schoonhoven"

Are you Sushilla Van Schoonhoven?   Register this Author

16Publications

354Reads

44Profile Views

Synthesis and biological evaluation of biotin-conjugated anticancer thiosemicarbazones and their iron(III) and copper(II) complexes.

J Inorg Biochem 2019 01 19;190:85-97. Epub 2018 Oct 19.

Institute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Waehringer Str. 42, A-1090 Vienna, Austria; Research Cluster "Translational Cancer Therapy Research", Vienna, Austria.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01620134183035
Publisher Site
http://dx.doi.org/10.1016/j.jinorgbio.2018.10.006DOI Listing
January 2019

The Natural Fungal Metabolite Beauvericin Exerts Anticancer Activity In Vivo: A Pre-Clinical Pilot Study.

Toxins (Basel) 2017 08 24;9(9). Epub 2017 Aug 24.

Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, and Comprehensive Cancer Center of the Medical University, Borschkegasse 8a, 1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/toxins9090258DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618191PMC
August 2017

Distinct activity of the bone-targeted gallium compound KP46 against osteosarcoma cells - synergism with autophagy inhibition.

J Exp Clin Cancer Res 2017 04 12;36(1):52. Epub 2017 Apr 12.

Department of Medicine I, Institute of Cancer Research and Comprehensive Cancer Center, Medical University Vienna, Borschkegasse 8a, A-1090, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13046-017-0527-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389188PMC
April 2017

Loss of phosphodiesterase 4D mediates acquired triapine resistance via Epac-Rap1-Integrin signaling.

Oncotarget 2016 Dec;7(51):84556-84574

Department of Medicine I, Institute of Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.11821DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356681PMC
December 2016

Trabectedin Is Active against Malignant Pleural Mesothelioma Cell and Xenograft Models and Synergizes with Chemotherapy and Bcl-2 Inhibition In Vitro.

Mol Cancer Ther 2016 10 10;15(10):2357-2369. Epub 2016 Aug 10.

Applied and Experimental Oncology, Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-15-0846DOI Listing
October 2016

Differences in protein binding and excretion of Triapine and its Fe(III) complex.

J Inorg Biochem 2016 07 19;160:61-9. Epub 2015 Oct 19.

Institute of Inorganic Chemistry, University of Vienna, Waehringer Strasse 42, 1090 Vienna, Austria; Research Platform "Translational Cancer Therapy Research", University of Vienna and Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jinorgbio.2015.10.006DOI Listing
July 2016

EGFR is not a major driver for osteosarcoma cell growth in vitro but contributes to starvation and chemotherapy resistance.

J Exp Clin Cancer Res 2015 Nov 2;34:134. Epub 2015 Nov 2.

Institute of Cancer Research and Comprehensive Cancer Center, Department of Medicine I, Medical University Vienna, Borschkegasse 8a, 1090, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13046-015-0251-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630894PMC
November 2015